|
CN111372936A
|
|
Mcl-1 selective inhibitors, their preparation and use
|
|
CN110950890A
|
|
Substituted imidazo [4,5-c ] quinoline macrocycles as multi-target kinase inhibitors
|
|
CN110950889A
|
|
Multi-target kinase inhibitor and preparation method and application thereof
|
|
CN110452253A
|
|
Mcl-1 selective depressant and its preparation and use
|
|
CN109824690A
|
|
Mcl-1 selective depressant and its preparation and use
|
|
WO2018041248A1
|
|
Bcl-2 selective inhibitor and preparation and use thereof
|
|
CN109293656A
|
|
Bcl-2 selective depressant and its preparation and use
|
|
CN108727381A
|
|
A kind of salt and preparation method thereof of alk tyrosine kinase inhibitor
|
|
CN108653218A
|
|
The pharmaceutical preparations composition of Pyrrolopyrimidine derivatives and preparation method thereof as ALK/FAK/IGF1R multi-kinase inhibitors
|
|
CN108653231A
|
|
Composition and preparation method thereof containing bruton's tyrosine kinase inhibitor
|
|
CN108570036A
|
|
A kind of polymorph and preparation method thereof of BTK inhibitor
|
|
CN108456210A
|
|
A kind of polymorph and preparation method thereof of alk tyrosine kinase inhibitor
|
|
CN108341774A
|
|
Substituted quinolinones inhibitor
|
|
TW201726677A
|
|
P-toluenesulfonate salt for regulating kinase compound, and crystals thereof
|
|
CN108276410A
|
|
A kind of anaplastic lymphoma kinase inhibitor and its preparation method and application
|
|
CN108368115A
|
|
The salt of Pyrrolopyrimidine compounds
|
|
US2018346418A1
|
|
Kinase activity regulating compound intermediates preparation method
|
|
CN107936024A
|
|
A kind of anaplastic lymphoma kinase inhibitor and its preparation method and application
|
|
CN107793412A
|
|
The selective depressants of Bcl 2 and its preparation and use
|
|
CN107513067A
|
|
Pyrrolopyrimidine compounds containing substituted cyclopenta
|
